Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients

Kelda Gardner, PA-C, MHS, Elihu H. Estey, MD, Weigang Tong, MD, Robert McCroskey, MD, Roland B. Walter, MD PhD MS, Paul C. Hendrie, MD PhD, Bart L. Scott, MD MS, Andrea M. Perdue, PA-C, Mary-Elizabeth M. Percival, MD MS, Heather A. Smith, PA-C, Cody Hammer, Pamela S. Becker, MD PhD

Blood (2016) 128 (22): 5207.

https://doi.org/10.1182/blood.V128.22.5207.5207

Published: 2016

Journal Articles

Pathophysiology of Macrocytic Anemia in Diamond Blackfan Anemia and Del(5q) Myelodysplastic Syndrome

Zhantao Yang, MD, Sioban B. Keel, MD, Brent L. Wood, MDPhD, Bart L. Scott, MD MS, Janis L. Abkowitz, MD

Blood (2015) 126 (23): 670.

https://doi.org/10.1182/blood.V126.23.670.670

Published: 2015

Journal Articles

Late Relapse After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Aaron T Gerds, MD, MS, Bart L Scott, MD, MS, Min Fang, MD, PhD, H. Joachim Deeg, MD

Blood (2012) 120 (21): 1969.

https://doi.org/10.1182/blood.V120.21.1969.1969

Published: 2012

Journal Articles

Multicenter Phase 2 Trial of G-CSF Priming, Clofarabine, and High Dose Cytarabine (GCLAC) for Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome or Advanced Myeloproliferative Neoplasm

Pamela S. Becker, MD, PhD, Bruno C. Medeiros, MD, Anthony Selwyn Stein, M.D., Frederick R. Appelbaum, MD, Bart L Scott, MD, MS, Colleen Delaney, MD, MSc, Megan Othus, PhD, Paul C. Hendrie, MD, PhD, Kelda M. Gardner, PA-C, Stephen Petersdorf, MD, John M. Pagel, MD, PhD, Roland B. Walter, MD, PhD, Cynthia Parks, Elihu H. Estey, MD

Blood (2012) 120 (21): 3594.

https://doi.org/10.1182/blood.V120.21.3594.3594

Published: 2012

Journal Articles

Safety and Efficacy of Oral Azacitidine (CC-486) Administered in Extended Treatment Schedules to Patients with Lower-Risk Myelodysplastic Syndromes

Guillermo Garcia-Manero, MD, Steven D. Gore, MD, Suman Kambhampati, MD, Bart L Scott, MD, MS, Ayalew Tefferi, MD, Christopher R Cogle, MD, William Edenfield, MD, Joel Hetzer, PhD, Keshava Kumar, PhD, Barry S. Skikne, MD

Blood (2012) 120 (21): 424.

https://doi.org/10.1182/blood.V120.21.424.424

Published: 2012

Journal Articles

Heme Excess Impairs the Maturation of Proerythroblasts From Patients with Diamond Blackfan Anemia (DBA) and 5q- Myelodysplastic Syndrome (MDS)

Zhantao Yang, MD, Sioban B Keel, MD, Akiko Shimamura, MD, PhD, Aaron T. Gerds, MD, Bart L. Scott, MD, MS, Janis L. Abkowitz, MD

Blood (2012) 120 (21): 514.

https://doi.org/10.1182/blood.V120.21.514.514

Published: 2012

Journal Articles

Safety and Efficacy of Bendamustine and Idarubicin in Combination Therapy for Patients Age ≥50 with Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome – Results From a Phase I/II Adaptive Design Study.

Mazyar Shadman, MD, MPH, Jack M. Lionberger, MD, PhD, Raya Mawad, MD, Ravinder K Sandhu, MD, Carol Dean, RN, Kathleen Shannon-Dorcy, RN, Kyle Wathen, PhD, Bart L Scott, MD, MS, Roland B. Walter, MD, PhD, Pamela S. Becker, MD, PhD, Frederick R. Appelbaum, MD, Elihu H. Estey, MD, John M. Pagel, MD, PhD

Blood (2012) 120 (21): 2622.

https://doi.org/10.1182/blood.V120.21.2622.2622

Published: 2012

Journal Articles

Low Albumin, High Ferritin, and Thrombocytopenia Before Transplant Predict Non-Relapse Mortality (NRM) Independent of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI).

Mohamed L Sorror, MD, MSc, Barry E Storer, PhD, Gary Schoch, Brenda M Sandmaier, MD, Paul J Martin, MD, Bart L Scott, MD, MS, H. Joachim Deeg, MD, Frederick R Appelbaum, MD, David G Maloney, MD, PhD, Rainer F Storb, MD

Blood (2009) 114 (22): 651.

https://doi.org/10.1182/blood.V114.22.651.651

Published: 2009

NARROW

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients

Pathophysiology of Macrocytic Anemia in Diamond Blackfan Anemia and Del(5q) Myelodysplastic Syndrome

Late Relapse After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Multicenter Phase 2 Trial of G-CSF Priming, Clofarabine, and High Dose Cytarabine (GCLAC) for Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome or Advanced Myeloproliferative Neoplasm

Safety and Efficacy of Oral Azacitidine (CC-486) Administered in Extended Treatment Schedules to Patients with Lower-Risk Myelodysplastic Syndromes

Heme Excess Impairs the Maturation of Proerythroblasts From Patients with Diamond Blackfan Anemia (DBA) and 5q- Myelodysplastic Syndrome (MDS)

Safety and Efficacy of Bendamustine and Idarubicin in Combination Therapy for Patients Age ≥50 with Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome – Results From a Phase I/II Adaptive Design Study.

Low Albumin, High Ferritin, and Thrombocytopenia Before Transplant Predict Non-Relapse Mortality (NRM) Independent of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only